Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics.

MLA

Li, Lian, et al. “Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics.” ACS Nano, vol. 12, no. 4, Apr. 2018, pp. 3658–70. EBSCOhost, https://doi.org/10.1021/acsnano.8b00797.

APA

Li, L., Yang, J., Wang, J., & Kopeček, J. (2018). Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics. ACS Nano, 12(4), 3658–3670. https://doi.org/10.1021/acsnano.8b00797

Chicago

Li, Lian, Jiyuan Yang, Jiawei Wang, and Jindřich Kopeček. 2018. “Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics.” ACS Nano 12 (4): 3658–70. doi:10.1021/acsnano.8b00797.